In a filing, Encompass Health Corp revealed its EVP & Chief Financial Officer COLTHARP DOUGLAS E unloaded Company’s shares for reported $0.71 million on Nov 13 ’23. In the deal valued at $63.39 per share,11,215 shares were sold. As a result of this transaction, COLTHARP DOUGLAS E now holds 116,293 shares worth roughly $9.57 million.
Then, Charbonneau Elissa Joy sold 8,294 shares, generating $577,097 in total proceeds. Upon selling the shares at $69.58, the Chief Medical Officer now owns 23,081 shares.
Before that, Tarr Mark J sold 25,330 shares. Encompass Health Corp shares valued at $1,799,950 were divested by the President & CEO at a price of $71.06 per share. As a result of the transaction, Tarr Mark J now holds 497,405 shares, worth roughly $40.94 million.
Barclays initiated its Encompass Health Corp [EHC] rating to an Overweight in a research note published on March 06, 2024; the price target was $95. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in mid March with a ‘”an Equal weight”‘ rating. UBS began covering EHC with “Buy” recommendation on September 24, 2021. Raymond James revised its rating on August 02, 2021. It rated EHC as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of EHC
On Monday, Encompass Health Corp [NYSE:EHC] saw its stock fall -1.26% to $82.31. Over the last five days, the stock has lost -1.11%. Encompass Health Corp shares have risen nearly 23.37% since the year began. Nevertheless, the stocks have risen 34.78% over the past one year. While a 52-week high of $83.73 was reached on 03/28/24, a 52-week low of $57.55 was recorded on 01/02/24. SMA at 50 days reached $75.67, while 200 days put it at $69.20. A total of 0.63 million shares were traded, compared to the trading of 0.96 million shares in the previous session.
Levels Of Support And Resistance For EHC Stock
The 24-hour chart illustrates a support level at 81.98, which if violated will result in even more drops to 81.65. On the upside, there is a resistance level at 82.90. A further resistance level may holdings at 83.50. The Relative Strength Index (RSI) on the 14-day chart is 64.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.58, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 18.64%. Stochastics %K at 82.84% indicates the stock is a selling.
How much short interest is there in Encompass Health Corp?
A steep rise in short interest was recorded in Encompass Health Corp stocks on Mar 15, 2024, dropping by -0.17 million shares to a total of 2.29 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.46 million shares. There was a decline of -7.42%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.62% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.69.
